TAG - Treatment Action Group

Basic Science
& Vaccine Blog

Making Memories That Last a Lifetime

Waheedah Shabaaz-El at opening Plenary: History and Current Challenges of HIV Prevention and Treatment Research Advocacy

A multi-institutional team has been awarded a $21 million Program Project Grant to dissect the early innate immune re...

If you weren't able to attend IAS in Vienna, you can watch many of the presentations online. Here's how.

This session from the 2010 AIDS Conference in Vienna debated the pros and cons of early initiation and highlighted th...

The CD4 cell count at which combination antiretroviral therapy should be started is a central, unresolved issue in ...

The National Institute of Allergy and Infectious Diseases (NIAID) and National Institute of Mental Health (NIMH), b...

Working to speed the development and delivery of safer, more tolerable, and more effective antiretroviral drugs to people with HIV worldwide.

Advocating for effective immune-based therapies, vaccines, preventive technologies, and a cure for AIDS.

Advancing domestic and global policies toward affordable, accessible, and equitable access to quality primary health care for all.

Working to develop research and policies to improve care and treatment for all people with hepatitis B, hepatitis C, and HIV.

Strengthening advocacy to improve health outcomes for people with TB/HIV worldwide.